digital cash Block

Navigation warning! Military training in the South China Sea. According to the website of China Maritime Safety Administration, the Qingyan Maritime Safety Administration issued a navigation warning. From 8: 00 to 18: 00 on December 13, military training was conducted in parts of the South China Sea, and it was forbidden to enter.The weighted share price index of Taiwan Stock Exchange opened 0.6% higher at 23,050.64.According to the information on the suspension and resumption of trading of the Shanghai Stock Exchange, Hasen shares were not announced due to important matters, and they were suspended all day on December 12.

Game stocks fluctuated, raising the daily limit of Xinghui Entertainment, Xinghui Entertainment, Fuchun Shares, Youzu Network, day boat culture, Tomcat and Zhongqingbao.Xinwei International (00058.HK) once rose by 90% when it resumed trading, but now the increase has narrowed to less than 50%.The South Korean prosecutor once again summoned Brother Lv Yinxiong, the anti-espionage commander of the Ministry of National Defense. On the 12th local time, the South Korean prosecutor once again summoned Brother Lv Yinxiong, the core figure of the "emergency martial law incident". (CCTV News)

The turnover of Shanghai, Shenzhen and Beijing has exceeded 500 billion yuan. Up to now, the turnover of Shanghai, Shenzhen and Beijing has exceeded 500 billion yuan, including 183 billion yuan, 315.5 billion yuan and 4.6 billion yuan respectively.Baolingbao and Fengli Jingqiu reached a strategic cooperation. On December 11th, Baolingbao Biological Co., Ltd. (referred to as "Baolingbao") and Beijing Fengli Jingqiu Pharmaceutical Co., Ltd. (referred to as "Fengli Jingqiu") formally signed an agreement to start the strategic cooperation of lactulose bulk drug products. The two sides will carry out global technology and market expansion in the field of pharmaceutical raw materials.Baolingbao and Fengli Jingqiu reached a strategic cooperation. On December 11th, Baolingbao Biological Co., Ltd. (referred to as "Baolingbao") and Beijing Fengli Jingqiu Pharmaceutical Co., Ltd. (referred to as "Fengli Jingqiu") formally signed an agreement to start the strategic cooperation of lactulose bulk drug products. The two sides will carry out global technology and market expansion in the field of pharmaceutical raw materials.